The comparison of CD4/CD8 ratio among high and ordinary background radiation areas in Ramsar, Iran
by Sajad Borzoueisileh; Ali Shabestani Monfared; Saeid Abediankenari; Amrollah Mostafazadeh; Meysam Khosravifarsani; Mehrangiz Amiri; Farideh Elahimanesh
International Journal of Low Radiation (IJLR), Vol. 8, No. 4, 2011

Abstract: The High Natural Background Radiation Area (HNBRA) of Ramsar has been the subject of concern in the last 40 years for a high level of radiation measured in some spots as high as 260 mSv per year. Studies of health status of Ramsar inhabitants did not show significant increase in the frequency of cancer. In this study, some aspects of the immune surveillance in the HNBRA residents of Ramsar were investigated. Our results showed that the CD4+ and CD8+ percentage in residents of HNBRA was higher compared to the Ordinary Natural Background Radiation Area (ONBRA) inhabitants. However, the difference between CD4+ also CD8+ cells count and CD4/CD8 ratio in two areas was not significant statistically. These findings may indicate that the immune systems of these people are adapted but more studies to compare the function of immune systems between two groups become essential.

Online publication date: Sat, 07-Feb-2015

The full text of this article is only available to individual subscribers or to users at subscribing institutions.

 
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.

Pay per view:
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.

Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Low Radiation (IJLR):
Login with your Inderscience username and password:

    Username:        Password:         

Forgotten your password?


Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.

If you still need assistance, please email subs@inderscience.com